ADTX Stock Analysis: Buy, Sell, or Hold?
ADTX - Aditxt, Inc. Common Stock
$0.43
-0.04 (-8.58%)
▼
5d:
-9.49%
30d:
-39.76%
90d:
-82.5%
HOLD
LOW Confidence
Analysis Updated: Mar 5, 2026 12:00 AM ET
Earnings: Mar 02, 2026
0d
Get Alerted When ADTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called ADTX this week
67% bullish • 1 bearish
67% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ADTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ADTX is currently trading at $0.43, which is considered oversold relative to its 30-day fair value range of $0.49 to $0.79.
Technical Outlook: Technically, ADTX is in a downtrend. The price is currently testing key support at $0.43. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.00 (+12752.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADTX is in a downtrend. The price is currently testing key support at $0.43. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.00 (+12752.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.49 -
$0.79
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.6%)
- BULLISH: Trading 12752.9% below Wall St target ($61.00)
- CAUTION: Recommendation downgraded due to -9.5% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.49 -
$0.79
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.43
Resistance Level
$0.56
Current Trend
Downtrend
Technical data as of
Mar 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.37
Wall Street Target
$61.00
(+12752.9%)
Revenue Growth (YoY)
-89.1%
Share & Embed Analysis
Last updated: March 06, 2026 6:15 AM ET
Data refreshes hourly during market hours. Next update: 7:15 AM
Data refreshes hourly during market hours. Next update: 7:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Brian Michael Brady
SELL
1 shares
2025-12-17
Corinne Pankovcin
SELL
1 shares
2025-11-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$63 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 44 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1028 | 52 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 46 HOLD |
